Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus

Nestor Villamizar, Aurora D. Pryor

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Remission of type 2 diabetes mellitus with metabolic surgery is a field of active investigation and development. The extraordinary results obtained in diabetic patients with BMI > 35 kg/m2 have led investigators to query if similar results could be achieved in patients with BMI < 35 kg/m2. A few studies have been recently conducted to evaluate the safety, effectiveness, and cost effectiveness of bariatric surgery in diabetic patients with BMI BMI < 35 kg/m2. However, stronger evidence would be required before insurance coverage is extended for bariatric surgery to all type 2 diabetic patients, in addition to those with BMI ≥ 35 kg/m2 for whom eligibility is already established. In addition, the hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery are yet to be determined. This paper will review the evidence about safety, effectiveness, and cost effectiveness of bariatric surgery in type 2 diabetes mellitus remission and the potential socioeconomic impact of offering bariatric surgery to diabetic patients with BMI BMI < 35 kg/m2.

Original languageEnglish (US)
Article number790683
JournalJournal of Obesity
Volume2011
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Bariatric Surgery
Type 2 Diabetes Mellitus
Cost-Benefit Analysis
Safety
Therapeutics
Insurance Coverage
Research Personnel

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus. / Villamizar, Nestor; Pryor, Aurora D.

In: Journal of Obesity, Vol. 2011, 790683, 2011.

Research output: Contribution to journalArticle

@article{8e7c75766a3f48669b8eee576e822fc1,
title = "Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus",
abstract = "Remission of type 2 diabetes mellitus with metabolic surgery is a field of active investigation and development. The extraordinary results obtained in diabetic patients with BMI > 35 kg/m2 have led investigators to query if similar results could be achieved in patients with BMI < 35 kg/m2. A few studies have been recently conducted to evaluate the safety, effectiveness, and cost effectiveness of bariatric surgery in diabetic patients with BMI BMI < 35 kg/m2. However, stronger evidence would be required before insurance coverage is extended for bariatric surgery to all type 2 diabetic patients, in addition to those with BMI ≥ 35 kg/m2 for whom eligibility is already established. In addition, the hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery are yet to be determined. This paper will review the evidence about safety, effectiveness, and cost effectiveness of bariatric surgery in type 2 diabetes mellitus remission and the potential socioeconomic impact of offering bariatric surgery to diabetic patients with BMI BMI < 35 kg/m2.",
author = "Nestor Villamizar and Pryor, {Aurora D.}",
year = "2011",
doi = "10.1155/2011/790683",
language = "English (US)",
volume = "2011",
journal = "Journal of Obesity",
issn = "2090-0708",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus

AU - Villamizar, Nestor

AU - Pryor, Aurora D.

PY - 2011

Y1 - 2011

N2 - Remission of type 2 diabetes mellitus with metabolic surgery is a field of active investigation and development. The extraordinary results obtained in diabetic patients with BMI > 35 kg/m2 have led investigators to query if similar results could be achieved in patients with BMI < 35 kg/m2. A few studies have been recently conducted to evaluate the safety, effectiveness, and cost effectiveness of bariatric surgery in diabetic patients with BMI BMI < 35 kg/m2. However, stronger evidence would be required before insurance coverage is extended for bariatric surgery to all type 2 diabetic patients, in addition to those with BMI ≥ 35 kg/m2 for whom eligibility is already established. In addition, the hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery are yet to be determined. This paper will review the evidence about safety, effectiveness, and cost effectiveness of bariatric surgery in type 2 diabetes mellitus remission and the potential socioeconomic impact of offering bariatric surgery to diabetic patients with BMI BMI < 35 kg/m2.

AB - Remission of type 2 diabetes mellitus with metabolic surgery is a field of active investigation and development. The extraordinary results obtained in diabetic patients with BMI > 35 kg/m2 have led investigators to query if similar results could be achieved in patients with BMI < 35 kg/m2. A few studies have been recently conducted to evaluate the safety, effectiveness, and cost effectiveness of bariatric surgery in diabetic patients with BMI BMI < 35 kg/m2. However, stronger evidence would be required before insurance coverage is extended for bariatric surgery to all type 2 diabetic patients, in addition to those with BMI ≥ 35 kg/m2 for whom eligibility is already established. In addition, the hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery are yet to be determined. This paper will review the evidence about safety, effectiveness, and cost effectiveness of bariatric surgery in type 2 diabetes mellitus remission and the potential socioeconomic impact of offering bariatric surgery to diabetic patients with BMI BMI < 35 kg/m2.

UR - http://www.scopus.com/inward/record.url?scp=80455166442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455166442&partnerID=8YFLogxK

U2 - 10.1155/2011/790683

DO - 10.1155/2011/790683

M3 - Article

AN - SCOPUS:80455166442

VL - 2011

JO - Journal of Obesity

JF - Journal of Obesity

SN - 2090-0708

M1 - 790683

ER -